エンビュー・メディカル
ENvue Medical, Inc.
NanoVibronix, Inc. engages in the development of noninvasive biological response-activating devices. The firm's products include UroShield and PainShield. It operates through the following geographical segments: United States, Europe, Australia, India, Israel, and Other. The company was founded by Harold Jacob and Jona Zumeris in September 2003 and is headquartered in Tyler, TX.
| Period | EPS | Revenue | FCF |
|---|---|---|---|
| 2026 Q1 | -6877.67 | $653,000 | -$4M |
| 2025 Q4 | -15.87 | $312,000 | -$3M |
| 2025 Q3 | -0.91 | $722,000 | -$2M |
| 2025 Q2 | -10.30 | $494,000 | -$3M |
| 2025 Q1 | -39.80 | $1M | -$1M |
| 2024 Q4 | -45.09 | $444,000 | — |
| 2024 Q3 |
| -39.16 |
| $376,000 |
| -$836,000 |
| 2024 Q2 | -27.18 | $817,000 | -$555,000 |